The cancer nanomedicine research group, located at the Knight Cancer Institute of OHSU, aims to understand and use interactions of nanomaterials with biological systems to design effective cancer nanomedicines.

Our ultimate goal is to translate our findings into the clinic to improve the outcomes and quality of life of cancer patients.